Membrane Protein Production and Structure Determination (R01)

The summary for the Membrane Protein Production and Structure Determination (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Membrane Protein Production and Structure Determination (R01): This RFA solicits applications to enhance the rate of membrane protein structure determination and to facilitate the determination of membrane protein structures. Methods development for expression, solubilization, stabilization, purification, characterization, crystallization, isotopic labeling of membrane proteins, and for determination of their structures by electron microscopic, x-ray diffraction, nuclear magnetic resonance (NMR) and mass spectrometry, and other biophysical techniques are emphasized. It is a follow-on to the NIH Roadmap RFA-RM-04-026 with updates and modification of the mechanisms of grant support that are to be used.

Federal Grant Title:	Membrane Protein Production and Structure Determination (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-RM-07-003
Type of Funding:	Grant
CFDA Numbers:	93.310
CFDA Descriptions:	Trans-NIH Research Support
Current Application Deadline:	No deadline provided
Original Application Deadline:	Oct 28, 2006
Posted Date:	Aug 31, 2006
Creation Date:	Aug 31, 2006
Archive Date:	Nov 27, 2006
Total Program Funding:	$1,600,000
Maximum Federal Grant Award:	$250,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Special district governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses County governments City or township governments Private institutions of higher education
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. None
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial No...; • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...; • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional); • NIH Directors Early Independence Awards (DP5 Clinical Trial Optional); • NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional); • Using Metabolomics to Investigate Biological Pathways and Networks (R01); • Assay Development for High Throughput Molecular Screening (R21); • Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Scre...
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...